Matinas BioPharma
MTNB
$0.16
Share price
-5.42%
Change (1 day)
-56.86%
Change (1 year)
Categories
Matinas BioPharma (MTNB) - Net assets
Net assets on the balance sheet as of March 2024 : $14.55 M
According to Matinas BioPharma's latest financial reports the company has $14.55 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Matinas BioPharma - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $36.63 M | -30.21% |
| 2021-12-31 | $52.49 M | -17.63% |
| 2020-12-31 | $63.73 M | 92.82% |
| 2019-12-31 | $33.05 M | 104.76% |
| 2018-12-31 | $16.14 M | 51.11% |
| 2017-12-31 | $10.68 M | 49.4% |
| 2016-12-31 | $7.14 M | 17.75% |
| 2015-12-31 | $6.07 M | 172.56% |
| 2014-12-31 | $2.22 M | -78.73% |
| 2013-12-31 | $10.47 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | 2,157.49% | 🇺🇸 USA |